Understanding the causes of type1 diabetes (T1D) and finding early disease markers seem the only way forward to reduce disease incidence. Based on this, the DIAPREPP consortium set out to identify and exploit early events in the development of autoimmunity against islet beta antigens in a large cohort of children.
Further information: cordis.europa.eu